BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29685967)

  • 21. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
    Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
    Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.
    Dieckmann KP; Spiekermann M; Balks T; Ikogho R; Anheuser P; Wosniok W; Loening T; Bullerdiek J; Belge G
    Urol Int; 2016; 97(1):76-83. PubMed ID: 26989896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.
    Alonso-Crisostomo L; Trendell J; Ferraresso M; Bailey S; Ward D; Scurlock ZGL; Wenlock SC; Bastos CAP; Jugdaohsingh R; Faria NJ; Enright AJ; Scarpini CG; Coleman N; Murray MJ
    Int J Cancer; 2024 Jan; 154(2):372-388. PubMed ID: 37632231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males.
    Spiller CM; Lobo J; Boellaard WPA; Gillis AJM; Bowles J; Looijenga LHJ
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32210110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?
    Spiekermann M; Dieckmann KP; Balks T; Bullerdiek J; Belge G
    Anticancer Res; 2015 Jan; 35(1):117-21. PubMed ID: 25550541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis.
    Liu Q; Lian Q; Lv H; Zhang X; Zhou F
    Mol Diagn Ther; 2021 May; 25(3):273-281. PubMed ID: 33886084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
    J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up.
    Chavarriaga J; Hamilton RJ
    Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
    Dieckmann KP; Hennig F; Anheuser P; Gehrckens R; Viehweger F; Wülfing C; Belge G
    Urol Int; 2021; 105(1-2):21-26. PubMed ID: 33049748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis.
    Piao J; Lafin JT; Scarpini CG; Nuño MM; Syring I; Dieckmann KP; Belge G; Ellinger J; Amatruda JF; Bagrodia A; Coleman N; Krailo MD; Frazier AL; Murray MJ
    Clin Genitourin Cancer; 2021 Dec; 19(6):469-479. PubMed ID: 34629299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic alterations of testicular germ cell tumours.
    Ilijazi D; Shariat SF; Hassler MR; Lemberger U; Ertl IE
    Curr Opin Urol; 2020 Mar; 30(2):264-270. PubMed ID: 31905176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
    Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
    Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA.
    Tanaka K; Kondo K; Kitajima K; Muraoka M; Nozawa A; Hara T
    J Biol Chem; 2013 Aug; 288(33):23990-9. PubMed ID: 23843459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining Hypermethylated
    Lobo J; van Zogchel LMJ; Nuru MG; Gillis AJM; van der Schoot CE; Tytgat GAM; Looijenga LHJ
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy.
    Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives.
    Ditonno F; Franco A; Manfredi C; Fasanella D; Abate M; La Rocca R; Crocerossa F; Iossa V; Falagario UG; Cirillo L; Altieri VM; Di Mauro E; Crocetto F; Barone B; Cilio S; Pandolfo SD; Aveta A; Mirone V; Franzese CA; Arcaniolo D; Napolitano L
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004082
    [No Abstract]   [Full Text] [Related]  

  • 38. Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review.
    Leão R; Albersen M; Looijenga LHJ; Tandstad T; Kollmannsberger C; Murray MJ; Culine S; Coleman N; Belge G; Hamilton RJ; Dieckmann KP
    Eur Urol; 2021 Oct; 80(4):456-466. PubMed ID: 34175151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population.
    Kılınç MT; Göger YE; Özkent MS; Kılıç Ö; Okur Altındaş B; Yıldırım MS; Karalezli G
    Urol J; 2024 Jun; 21(4):242-249. PubMed ID: 38629199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.
    Dieckmann KP; Spiekermann M; Balks T; Flor I; Löning T; Bullerdiek J; Belge G
    Br J Cancer; 2012 Nov; 107(10):1754-60. PubMed ID: 23059743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.